Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism AMPA receptor antagonists(Glutamate receptor ionotropic AMPA antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H19N5O4S |
InChIKeyMCECSFFXUPEPDB-UHFFFAOYSA-N |
CAS Registry912574-69-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Selurampanel | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute migraine | Phase 3 | ES | 01 Apr 2009 | |
Epilepsies, Partial | Phase 2 | DE | 01 Jun 2010 | |
Epilepsies, Partial | Phase 2 | PL | 01 Jun 2010 | |
Epilepsies, Partial | Phase 2 | PL | 01 Jun 2010 | |
Acute migraine | Phase 2 | US | 01 Apr 2009 | |
Acute migraine | Phase 2 | DE | 01 Apr 2009 | |
Epilepsy | Phase 2 | DE | 01 Mar 2009 | |
Seizures | Phase 2 | DE | 01 Mar 2009 | |
Seizures | Phase 2 | DE | 01 Mar 2009 | |
Epilepsy, Reflex | Phase 2 | DE | 01 Oct 2008 |
NCT01302873 (Pubmed) Manual | Phase 2 | 96 | kbqnhktomw(lorsquufya) = hjnqlmchar craneoznfh (uurpugrrii ) View more | Positive | 01 Jan 2021 | ||
Placebo | kbqnhktomw(lorsquufya) = kqouhzhkjh craneoznfh (uurpugrrii ) View more | ||||||
Phase 2 | 59 | Dexamethasone Supression Test+BGG492 | eiallofneq(ivnsqywvzy) = ckwnqgwcjg cghnbmivkc (xlrcsjgupp, ivfbrxiwaa - eaavugincb) View more | - | 25 Jul 2016 | ||
Phase 2 | 75 | dcaspnjunm(xrvbubfkgt) = blodttmbhm zsjvlyxjro (uzjpdhpyla ) | - | 01 Feb 2014 | |||
dcaspnjunm(xrvbubfkgt) = tkqqmuheaz zsjvlyxjro (uzjpdhpyla ) |